Full Text View
Tabular View
No Study Results Posted
Related Studies
Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain
This study has been completed.
Study NCT00178945   Information provided by Vanderbilt University
First Received: September 12, 2005   Last Updated: August 16, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cervical Dystonia
Additional conditions recognized in this trial
Dystonia
Dystonic Disorders
Fibromyalgia
Myofascial Pain Syndromes
Syndrome
Torticollis
More general conditions related to this trial
Central Nervous System Diseases
Disease
Dyskinesias
Movement Disorders
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neurologic Manifestations
Neuromuscular Diseases
Pathologic Processes
Rheumatic Diseases
Signs and Symptoms
Interventions listed in this trial
Botulinum Toxin Type A
Additional drug interventions recognized in this trial
Botulinum Toxins
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Central Nervous System Agents
Neuromuscular Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Vanderbilt University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services